MAPT and Alzheimer disease: While the contribution made by altered brain cholesterol metabolism to the complex pathogenesis of AD has recently gained further consensus, the mechanisms linking this metabolic impairment to the hallmark lesions of AD, that is, extracellular Aβ deposits and intraneuronal tau pathology, have not yet been clarified.